| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |